Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Partelli

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
The Oncologist|November 10, 2017
Clinical Usefulness of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine NeoplasmsMaria Rinzivillo, Stefano Partelli, Daniela Prosperi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2023
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinomaGiulia Gasparini, Francesca Aleotti, Marco Palucci, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 25, 2025
Islet autotransplantation in focal intraductal papillary mucinous neoplasms: Evaluating feasibility, safety, and metabolic outcomes in pancreatic resectionFrancesca Aleotti, Gianpaolo Balzano, Raffella Melzi, et al.
American Journal of Surgery|March 27, 2020
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3Elettra Merola, Massimo Falconi, Anja Rinke, et al.
Critical Reviews in Oncology/Hematology|December 15, 2015
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinomaNicola Silvestris, Vito Longo, Francesco Cellini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2023
Somatostatin receptor activity assessed by <sup>68</sup>Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumorsPaola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 13, 2021
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelinesStefano Crippa, Alessandro Fogliati, Roberto Valente, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine NeoplasmsPaola Mapelli, Stefano Partelli, Matteo Salgarello, et al.
Pancreas|February 13, 2014
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcomeFrancesco Panzuto, Elettra Merola, Maria Rinzivillo, et al.
Annals of Surgical Oncology|March 8, 2024
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition"Giulio Belfiori, Stefano Crippa, Michele Pagnanelli, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
The Oncologist|November 10, 2017
Clinical Usefulness of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine NeoplasmsMaria Rinzivillo, Stefano Partelli, Daniela Prosperi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2023
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinomaGiulia Gasparini, Francesca Aleotti, Marco Palucci, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 25, 2025
Islet autotransplantation in focal intraductal papillary mucinous neoplasms: Evaluating feasibility, safety, and metabolic outcomes in pancreatic resectionFrancesca Aleotti, Gianpaolo Balzano, Raffella Melzi, et al.
American Journal of Surgery|March 27, 2020
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3Elettra Merola, Massimo Falconi, Anja Rinke, et al.
Critical Reviews in Oncology/Hematology|December 15, 2015
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinomaNicola Silvestris, Vito Longo, Francesco Cellini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2023
Somatostatin receptor activity assessed by <sup>68</sup>Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumorsPaola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 13, 2021
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelinesStefano Crippa, Alessandro Fogliati, Roberto Valente, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine NeoplasmsPaola Mapelli, Stefano Partelli, Matteo Salgarello, et al.
Pancreas|February 13, 2014
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcomeFrancesco Panzuto, Elettra Merola, Maria Rinzivillo, et al.
Annals of Surgical Oncology|March 8, 2024
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition"Giulio Belfiori, Stefano Crippa, Michele Pagnanelli, et al.
Pageof 29